GIFLF:OTCMKTS
Grifols SA Class A
$ 11.13
0.00%
(0.00) 1D
9-р сарын 15, 15:11:14 (GMT-4) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GIFLF...
Mkt. cap
6.56 тэрбум
Avg. vol.
543.00
Volume
0.00
52-wk high
$ 12.90
52-wk low
$ 10.13
Beta
0.86
Shares outstanding
426.13 сая
No. of employees
25 мян
Mkt. cap
6.56 тэрбум
Avg. vol.
543.00
Volume
0.00
52-wk high
$ 12.90
52-wk low
$ 10.13
Beta
0.86
Shares outstanding
426.13 сая
No. of employees
25 мян
News stories
From web sources and news partners
AD HOC NEWS
·
9 цагийн өмнө
Grifols stock reports 28.7 percent H1 profit growth
The New York Times
·
1 сарын өмнө
After 2 Plasma Donor Deaths, Company Pauses Clinics in Canada
Profile
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30.
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
About Grifols SA Class A